$2.80
0.062.19%
At close: Aug 21, 5:00 PM EST
$2.80
N/A
After Hours: Aug 21, 4:00 PM EST
Ovid Therapeutics Inc
OVIDNASDAQ
Ovid Therapeutics Earnings & Forecasts
Ovid Therapeutics (OVID) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Ovid Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.10 | $-0.11 | $-0.10 | $-0.15 |
| Actual | $-0.08 | $-0.12 | $0.06 | $-0.17 |
| Surprise | +20.0% | -9.09% | +160.0% | -13.3% |
| Revenue | ||||
| Estimate | $30000 | $60664 | $133560 | $238228 |
| Actual | $733000 | $0 | $718000 | $132000 |
| Surprise | +2343.3% | -100.0% | +437.6% | -44.6% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.09 | $-0.10 | $-0.10 | $-0.09 |
| Revenue | ||||
| Consensus | $25360 | $142800 | — | — |
